Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Biochemical Recurrence of Prostate Cancer: Initial Results with [18F]PSMA-1007 PET/CT

Frederik L. Giesel, Leon Will, Claudia Kesch, Martin Freitag, Christophe Kremer, Jonas Merkle, Oliver C. Neels, Jens Cardinale, Boris Hadaschik, Markus Hohenfellner, Klaus Kopka, Uwe Haberkorn and Clemens Kratochwil
Journal of Nuclear Medicine April 2018, 59 (4) 632-635; DOI: https://doi.org/10.2967/jnumed.117.196329
Frederik L. Giesel
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
2Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
3German Cancer Consortium (DKTK), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leon Will
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Kesch
4Department of Urology, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Freitag
2Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
5Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Kremer
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonas Merkle
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver C. Neels
6Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Cardinale
6Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boris Hadaschik
4Department of Urology, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Hohenfellner
4Department of Urology, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Kopka
6Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Haberkorn
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
2Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clemens Kratochwil
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 59 no. 4 632-635
DOI 
https://doi.org/10.2967/jnumed.117.196329
PubMed 
29419475

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 22, 2017
  • Accepted for publication December 19, 2017
  • Published online April 2, 2018.

Article Versions

  • previous version (February 1, 2018 - 11:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Frederik L. Giesel1–3,
  2. Leon Will1,
  3. Claudia Kesch4,
  4. Martin Freitag2,5,
  5. Christophe Kremer1,
  6. Jonas Merkle1,
  7. Oliver C. Neels6,
  8. Jens Cardinale6,
  9. Boris Hadaschik4,
  10. Markus Hohenfellner4,
  11. Klaus Kopka6,
  12. Uwe Haberkorn1,2 and
  13. Clemens Kratochwil1
  1. 1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  2. 2Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
  3. 3German Cancer Consortium (DKTK), Heidelberg, Germany
  4. 4Department of Urology, University Hospital Heidelberg, Heidelberg, Germany
  5. 5Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; and
  6. 6Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
  1. For correspondence or reprints contact: Frederik L. Giesel, Department of Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120 Heidelberg, Germany. E-mail: frederik{at}egiesel.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 52 Citations
  • 53 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
    Frederik L. Giesel, Karina Knorr, Fabian Spohn, Leon Will, Tobias Maurer, Paul Flechsig, Oliver Neels, Kilian Schiller, Horacio Amaral, Wolfgang A. Weber, Uwe Haberkorn, Markus Schwaiger, Clemens Kratochwil, Peter Choyke, Vasko Kramer, Klaus Kopka, Matthias Eiber
    Journal of Nuclear Medicine 2019 60 3
  • A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer
    Pieter J.L. De Visschere, Chloë Standaert, Jurgen J. Fütterer, Geert M. Villeirs, Valeria Panebianco, Jochen Walz, Tobias Maurer, Boris A. Hadaschik, Frédéric E. Lecouvet, Gianluca Giannarini, Stefano Fanti
    European Urology Oncology 2019 2 1
  • 68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy
    Andrea Farolfi, Francesco Ceci, Paolo Castellucci, Tiziano Graziani, Giambattista Siepe, Alessandro Lambertini, Riccardo Schiavina, Filippo Lodi, Alessio G. Morganti, Stefano Fanti
    European Journal of Nuclear Medicine and Molecular Imaging 2019 46 1
  • Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
    Kambiz Rahbar, Ali Afshar-Oromieh, Robert Seifert, Stefan Wagner, Michael Schäfers, Martin Bögemann, Matthias Weckesser
    European Journal of Nuclear Medicine and Molecular Imaging 2018 45 12
  • Detection Rate of 18F-Labeled PSMA PET/CT in Biochemical Recurrent Prostate Cancer: A Systematic Review and a Meta-Analysis
    Giorgio Treglia, Salvatore Annunziata, Daniele A. Pizzuto, Luca Giovanella, John O. Prior, Luca Ceriani
    Cancers 2019 11 5
  • Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer
    David A. Pattison, Maciej Debowski, Brook Gulhane, Evyn G. Arnfield, Anita M. Pelecanos, Peter L. Garcia, Melissa J. Latter, Charles Y. Lin, Matthew J. Roberts, Stuart C. Ramsay, Paul A. Thomas
    European Journal of Nuclear Medicine and Molecular Imaging 2022 49 2
  • PSMA-targeted Radiotracers versus 18F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis
    Nelly Tan, Udochukwu Oyoyo, Niusha Bavadian, Nicholas Ferguson, Anudeep Mukkamala, Jeremie Calais, Matthew S. Davenport
    Radiology 2020 296 1
  • Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art
    Raquel Perez-Lopez, Nina Tunariu, Anwar R. Padhani, Wim J. G. Oyen, Stefano Fanti, Hebert Alberto Vargas, Aurelius Omlin, Michael J. Morris, Johann de Bono, Dow-Mu Koh
    Radiology 2019 292 2
  • Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
    Sara Pastorino, Mattia Riondato, Licia Uccelli, Giampiero Giovacchini, Elisabetta Giovannini, Valerio Duce, Andrea Ciarmiello
    Current Radiopharmaceuticals 2020 13 1
  • Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on 18F-DCFPyL PET/CT Imaging
    Rudolf A. Werner, Ralph A. Bundschuh, Lena Bundschuh, Mehrbod S. Javadi, Jeffrey P. Leal, Takahiro Higuchi, Kenneth J. Pienta, Andreas K. Buck, Martin G. Pomper, Michael A. Gorin, Constantin Lapa, Steven P. Rowe
    Journal of Nuclear Medicine 2018 59 12

Article usage

Article usage: February 2018 to April 2025

AbstractFullPdf
Feb 20186350139
Mar 2018259051
Apr 2018120934126
May 20183952661
Jun 20181812729
Jul 2018971416
Aug 2018771216
Sep 2018130533
Oct 20181032845
Nov 2018442549
Dec 2018521738
Jan 2019741646
Feb 2019641041
Mar 2019662347
Apr 2019862053
May 2019531746
Jun 2019753953
Jul 2019523232
Aug 2019541047
Sep 2019373139
Oct 2019442939
Nov 2019622440
Dec 2019331324
Jan 2020301722
Feb 2020311532
Mar 2020362138
Apr 2020311525
May 2020343724
Jun 2020552842
Jul 2020311122
Aug 2020433168
Sep 2020412534
Oct 2020381425
Nov 2020311829
Dec 2020271928
Jan 2021162926
Feb 2021223228
Mar 2021137630
Apr 2021224239
May 2021123230
Jun 2021122113
Jul 2021102718
Aug 2021125822
Sep 2021133723
Oct 2021122326
Nov 2021114940
Dec 20211345293
Jan 2022103120
Feb 2022142922
Mar 2022214738
Apr 2022143925
May 2022122630
Jun 202263320
Jul 202224418
Aug 202239111
Sep 202273224
Oct 202252914
Nov 202273117
Dec 202283015
Jan 2023165724
Feb 202393520
Mar 2023134821
Apr 202361713
May 2023102021
Jun 202352010
Jul 2023131910
Aug 202392821
Sep 202354111
Oct 202388013
Nov 202365120
Dec 20231318
Jan 202442317
Feb 202482110
Mar 202452240
Apr 202427727
May 202434519
Jun 202454520
Jul 202473925
Aug 202473824
Sep 202423220
Oct 202492918
Nov 2024103823
Dec 202443516
Jan 2025183718
Feb 2025810034
Mar 2025167120
Apr 202586738
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (4)
Journal of Nuclear Medicine
Vol. 59, Issue 4
April 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biochemical Recurrence of Prostate Cancer: Initial Results with [18F]PSMA-1007 PET/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Biochemical Recurrence of Prostate Cancer: Initial Results with [18F]PSMA-1007 PET/CT
Frederik L. Giesel, Leon Will, Claudia Kesch, Martin Freitag, Christophe Kremer, Jonas Merkle, Oliver C. Neels, Jens Cardinale, Boris Hadaschik, Markus Hohenfellner, Klaus Kopka, Uwe Haberkorn, Clemens Kratochwil
Journal of Nuclear Medicine Apr 2018, 59 (4) 632-635; DOI: 10.2967/jnumed.117.196329

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Biochemical Recurrence of Prostate Cancer: Initial Results with [18F]PSMA-1007 PET/CT
Frederik L. Giesel, Leon Will, Claudia Kesch, Martin Freitag, Christophe Kremer, Jonas Merkle, Oliver C. Neels, Jens Cardinale, Boris Hadaschik, Markus Hohenfellner, Klaus Kopka, Uwe Haberkorn, Clemens Kratochwil
Journal of Nuclear Medicine Apr 2018, 59 (4) 632-635; DOI: 10.2967/jnumed.117.196329
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Intraoperative 68Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study
  • Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
  • Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on 18F-DCFPyL PET/CT Imaging
  • Google Scholar

More in this TOC Section

Theranostics

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Show more Theranostics

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • Peptides
  • PET/CT
  • biochemical recurrence
  • 18F-PSMA-1007
  • PSMA-PET
  • prostate cancer
SNMMI

© 2025 SNMMI

Powered by HighWire